SCHEMBL3433766

SCHEMBL3433766

COc1ccc(-c2cnn(C)c2)c(-c2cccc3[nH]ncc23)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 3/20 0.51
BRD4 O60885 1/20 0.48
BRAF P15056 4/20 0.47
PIM1 P11309 1/20 0.46
CCNA2 P20248 2/20 0.46
CDK2 P24941 2/20 0.46
TTK P33981 2/20 0.46
PIK3CA P42336 2/20 0.46
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
PDK2 Q15119 1/20 0.41
RAF1 P04049 3/20 0.41
LRRK2 Q5S007 1/20 0.40
TRPV1 Q8NER1 1/20 0.39
AXL P30530 1/20 0.39
PIK3CD O00329 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3435046 0.86 BRD4 (0.56) METAP2BRD4BRAFCCNA2CDK2
SCHEMBL2880810 0.83 METAP2 (0.47) METAP2BRD4BRAFCCNA2CDK2
SCHEMBL28640314 0.81 PIK3CA (0.52) METAP2BRD4BRAFTTKPIK3CA
SCHEMBL3435032 0.80 PIK3CA (0.42) METAP2BRD4BRAFPIM1CCNA2
SCHEMBL3435505 0.80 METAP2 (0.48) METAP2BRD4BRAFCCNA2CDK2
SCHEMBL2879628 0.75 BRD4 (0.50) METAP2BRD4BRAFPIK3CAMEN1
SCHEMBL28961950 0.74 BRAF (0.61) METAP2BRD4BRAFPIK3CAMEN1
SCHEMBL28635804 0.70 BRAF (0.51) METAP2BRD4BRAFPIK3CAMEN1
SCHEMBL3435497 0.70 METAP2 (0.46) METAP2BRD4BRAFPIK3CAPIK3CD
SCHEMBL15876525 0.70 METAP2 (0.44) METAP2BRD4BRAFPIK3CALRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2252616-A1 PYRAZOLOPYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE Genentech, Inc. (US) 2010-11-24 EP claimed
WO-2009097446-A1 PYRAZOLOPYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2009-08-06 WO claimed
CN-106659765-B Use of dianhydrogalactitol and analogs or derivatives thereof for treating non-small cell lung cancer and ovarian cancer 德玛医药 2021-08-13 CN disclosed